A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes
Clinical trial NCT04050670 · COMPLETED
Trial details
- NCT number
- NCT04050670
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-13
- Primary completion
- 2020-04-03
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.